Ind-Swift Limited
NSE: INDSWFTLTD BSE: 524652 SECTOR: Healthcare - Pharmaceuticals & Biotechnology
16 1(5%)
Volume
-
Open
28
High
28
Low
27
Close
15
VWAP
0
52 Week High
35
52 Week Low
12
Quality Score
58/100
Growth Score
66/100
Valuation Score
50/100
Momentum Score
0/100
Analyst Recommendations
BUY/SELL
|
|
Analyst Price Target
-
Market Cap (cr)
85
No. of Shares
P/E
2.07
P/B
-0.16
Face Value
2
Div. Yield
-
Book Value (TTM)
-
CASH
-
DEBT
-
EPS (TTM)
-
ROE
-7.95
ROCE
-
Profit Growth
-
Listing Date
18-Oct-04
Promoter Holding
55.58%
FII Holding
-
DII Holding
-
Price Chart
Price Performance
1 Week0
1 Month0
3 Months0
6 Months0
1 Year0
YTD0
Moving Average
5 Day SMA0
10 Day SMA0
20 Day SMA0
30 Day SMA0
50 Day SMA0
61 Day SMA0
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
| Standard | Camarilla | Fibonacci | Woodie's | |
|---|---|---|---|---|
| Resistance 3 | ||||
| Resistance 2 | ||||
| Resistance 1 | ||||
| Pivot Point | ||||
| Support 1 | ||||
| Support 2 | ||||
| Support 3 |
Competitors/Peers
| # | Symbol | MCAP | LTP | 1W | 1M | 6M | 1Y | P/E | Ind PE | Debt/Eq | NP Qtr Rs.Cr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SUNPHARMA | 4,68,099 | 1951 | 0% | 4% | 19% | 16% | 37 | 57.7 | 0.07 | 11509 |
| 2 | DIVISLAB | 1,93,792 | 7300 | 2% | 9% | 22% | 11% | 69 | 57.7 | 0 | 2568 |
| 3 | TORNTPHARM | 1,70,907 | 5050 | 0% | 13% | 25% | 42% | 72 | 57.7 | 1.79 | 2138 |
| 4 | APOLLOHOSP | 1,27,264 | 8851 | 0% | 6% | 31% | 21% | 58 | 57.7 | 0.9 | 2003 |
| 5 | CIPLA | 1,12,694 | 1395 | 2% | 0% | 3% | 4% | 22 | 57.7 | 0.02 | 3862 |
| 6 | ZYDUSLIFE | 1,10,623 | 1109 | 3% | 4% | 27% | 17% | 20 | 57.7 | 0.46 | 5124 |
| 7 | LUPIN | 1,09,686 | 2399 | 3% | 3% | 11% | 25% | 23 | 57.7 | 0.29 | 5355 |
| 8 | MANKIND | 1,05,603 | 2557 | 0% | 0% | 18% | 3% | 49 | 57.7 | 0.39 | 1938 |
| 9 | MAXHEALTH | 1,05,114 | 1080 | 2% | 1% | 8% | 14% | 0 | 57.7 | 0.32 | 1442 |
| 10 | DRREDDY | 97,638 | 1170 | 4% | 8% | 3% | 5% | 20 | 57.7 | 0.2 | 4158 |
| Load More | |||||||||||
Quarterly Results
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 145 | 120 | 136 | 114 | 135 | 103 | 116 | 149 | 106 | 107 | 104 | 95 | 106 | 104.35 | 97.37 | 90 |
| Sales Growth % (YoY) | 7.2% | 17.1% | 17.6% | -23.4% | 27.7% | -3.8% | 11.6% | 56.9% | 0.3% | 2.2% | 6.6% | 4.7% | - | - | - | - |
| Sales Growth % (QoQ) | 20.8% | -11.8% | 19.3% | -15.6% | 31.1% | -11.2% | -22.1% | 40.6% | -0.9% | 2.9% | 9.5% | -10.4% | 1.6% | 7.2% | 8.2% | - |
| Expenses | 148 | 112 | 122 | 111 | 121 | 98 | 105 | 130 | 98 | 89 | 93 | 90 | 96 | 92.32 | 84.69 | 80 |
| Operating Profit | -3 | 8 | 14 | 3 | 15 | 4 | 11 | 18 | 8 | 18 | 11 | 5 | 10 | 12.03 | 12.68 | 11 |
| OPM % | -2 | 7 | 11 | 3 | 11 | 4 | 10 | 12 | 8 | 17 | 11 | 5 | 9 | 11.53 | 13.02 | 12 |
| Other Income | 281 | 2 | 5 | 40 | 46 | 3 | 3 | 6 | 67 | 3 | 1 | 2 | 7 | 3.33 | 6.37 | 7 |
| Interest | 10 | 10 | 10 | 10 | 14 | 15 | 18 | 15 | 14 | 15 | 15 | 15 | 14 | 14.14 | 16.04 | 13 |
| Depreciation | 7 | 6 | 5 | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 7.99 | 7.95 | 8 |
| Profit before tax | 261 | -6 | 4 | 28 | 40 | -15 | -11 | 2 | 53 | -1 | -11 | -15 | -5 | -6.77 | -4.94 | -3 |
| Tax % | 2 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 |
| Net Profit | 257 | -6 | 4 | 28 | 38 | -15 | -11 | 2 | 53 | -1 | -11 | -15 | -5 | -6.77 | -4.94 | -4 |
| Net Profit Growth % (QoQ) | 4383.3% | -250% | -85.7% | -26.3% | 353.3% | -36.4% | -650% | -96.2% | 5400% | 90.9% | 26.7% | -200% | 26.1% | -37% | -23.5% | - |
| Net Profit Growth % (YoY) | 576.3% | 60% | 136.4% | 1300% | -28.3% | -1400% | - | 113.3% | 1160% | 85.2% | -122.7% | -275% | - | - | - | - |
| TTM Net Profit | 283 | 64 | 55 | 40 | 14 | 29 | 43 | 43 | 26 | -32 | -37.77 | -31.71 | -20.71 | -15.71 | -8.94 | 0 |
| EPS in Rs | 47.34 | -1.01 | 0.76 | 5.21 | 6.93 | -2.76 | -1.98 | 0.44 | 9.8 | -0.19 | -1.95 | -2.85 | -1.01 | -1.25 | -0.91 | -0.66 |
Profit and Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Sales | 515 | 502 | 411 | 398 | 270 | 263 | 308 |
| Sales Growth % | 2.6% | 22.2% | 3.3% | - | 2.6% | -14.5% | - |
| Expenses | 492 | 448 | 369 | 352 | 262 | 328 | 465 |
| Operating Profit | 23 | 54 | 42 | 45 | 8 | -65 | -157 |
| OPM % | 4 | 11 | 10 | 11 | 3 | -25 | -51 |
| Other Income | 328 | 53 | 72 | 24 | -20 | -246 | 13 |
| Interest | 39 | 63 | 60 | 57 | 7 | 16 | 19 |
| Depreciation | 24 | 27 | 29 | 32 | 35 | 36 | 36 |
| Profit before tax | 288 | 16 | 26 | -20 | -53 | -363 | -200 |
| Tax % | 2 | 14 | 0 | 2 | 1 | 0 | 0 |
| Net Profit | 283 | 14 | 26 | -20 | -50 | -373 | -214 |
| Net Profit Growth % | 1921.4% | -46.2% | 230% | 60% | 86.6% | -74.3% | - |
| EPS in Rs | 52.3 | 2.63 | 4.8 | -3.69 | -9.3 | -68.77 | -42.46 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flows
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 16 | 15 | 73 | 50 | 7 | -2 | -119 |
| Cash from Investing Activity | 3 | 77 | -29 | -18 | -6 | 4 | 10 |
| Cash from Financing Activity | -13 | -42 | -47 | -45 | -6 | -11 | 110 |
| Net Cash Flow | 6 | 50 | -3 | -13 | -5 | -8 | 0 |
Balance Sheet
| Mar 2025 | Sep 2024 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 10 |
| Reserves | -413 | -669 | -702 | -716 | -731 | -688 | -641 | -270 |
| Borrowings | 874 | 1023 | 1014 | 993 | 1036 | 1055 | 1062 | 1061 |
| Other Liabilities | 257 | 321 | 331 | 361 | 316 | 237 | 232 | 254 |
| Total Liabilities | 728 | 686 | 654 | 649 | 632 | 615 | 665 | 1055 |
| Fixed Assets | 243 | 166 | 184 | 216 | 236 | 311 | 342 | 374 |
| CWIP | 0 | 56 | 51 | 30 | 9 | 0 | 2 | 4 |
| Investments | 6 | 1 | 1 | 54 | 64 | 46 | 39 | 39 |
| Other Assets | 480 | 461 | 418 | 349 | 323 | 258 | 281 | 638 |
| Total Assets | 728 | 686 | 654 | 649 | 632 | 615 | 665 | 1055 |
Delivery
Daily Market Cap
No records found.
Stock Checklist
Price is below from 52 week high low average: 67%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings
No mutual fund holding data available.